4//SEC Filing
HORGAN KEVIN 4
Accession 0000899243-18-027399
CIK 0001609809other
Filed
Oct 23, 8:00 PM ET
Accepted
Oct 24, 5:58 PM ET
Size
5.4 KB
Accession
0000899243-18-027399
Insider Transaction Report
Form 4
HORGAN KEVIN
Chief Medical Officer and EVP
Transactions
- Award
Stock Option (right to buy)
2018-10-23+225,000→ 225,000 totalExercise: $6.58Exp: 2028-10-22→ Common Stock (225,000 underlying)
Footnotes (1)
- [F1]The Option will vest as to 25% of the shares on October 22, 2019. The remainder of the shares will vest in 12 equal quarterly installments thereafter
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
Related Parties
1- filerCIK 0001510614
Filing Metadata
- Form type
- 4
- Filed
- Oct 23, 8:00 PM ET
- Accepted
- Oct 24, 5:58 PM ET
- Size
- 5.4 KB